Provided by Tiger Trade Technology Pte. Ltd.

Harvard Apparatus Regenerative Technology Inc.

1.80
+0.11206.64%
Volume:750.00
Turnover:1.35K
Market Cap:31.65M
PE:-4.47
High:1.80
Open:1.80
Low:1.80
Close:1.69
52wk High:2.60
52wk Low:0.9359
Shares:17.58M
Float Shares:6.30M
Volume Ratio:0.21
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4028
EPS(LYR):-1.6870
ROE:-241.97%
ROA:-104.72%
PB:20.36
PE(LYR):-1.07

Loading ...

Company Profile

Company Name:
Harvard Apparatus Regenerative Technology Inc.
Exchange:
OTCQB
Establishment Date:
2009
Employees:
8
Office Location:
84 October Hill Road,Suite 11,Holliston,Massachusetts,United States
Zip Code:
01746
Fax:
- -
Introduction:
Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology combines the synthetic scaffold with tissue engineering and cell biology to create method of addressing organ damage. Its Cellframe technology stimulates the body's signaling pathways and natural healing process to regenerate and restore organ function. The company is developing organ implants as a platform of being used in the esophagus, trachea, and bronchi. Its implants are being advanced and tested in preclinical collaborative studies with Mayo Clinic and Connecticut Children's Medical Center. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2012 and is headquartered in Holliston, Massachusetts.